Mechanisms of HGF/Met Signaling to BRK and Sam68 in Breast Cancer Progression

Hormones and Cancer - United States
doi 10.1007/s12672-011-0097-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling

Cancers
Cancer ResearchOncology
2017English

Ror2 Signaling and Its Relevance in Breast Cancer Progression

Frontiers in Oncology
Cancer ResearchOncology
2017English

CXCL16/CXCR6 Chemokine Signaling Mediates Breast Cancer Progression by pERK1/2-dependent Mechanisms

Oncotarget
Oncology
2015English

Ran GTPase Promotes Cancer Progression via Met Receptormediated Downstream Signaling

Oncotarget
Oncology
2016English

Inhibition of HGF/MET Signaling Decreases Overall Tumor Burden and Blocks Malignant Conversion in Tpl2-Related Skin Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2019English

Met Kinetic Signature Derived From the Response to HGF/SF in a Cellular Model Predicts Breast Cancer Patient Survival

PLoS ONE
Multidisciplinary
2012English

Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage Over Inhibiting HGF/MET Signaling

Cancer Research
Cancer ResearchOncology
2015English

HGF/c-Met Axis Drives Cancer Aggressiveness in the Neoadjuvant Setting of Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

PAK1 Is a Breast Cancer Oncogene That Coordinately Activates MAPK and MET Signaling

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy